Seattle Genetics Inc $34.26

down -0.01


22/7/2014 04:00 PM  |  NASDAQ : SGEN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get SGEN Trend Analysis - it has underperformed the S&P 500 by 30%

Partner Headlines

  1. UPDATE: UBS Upgrades Seattle Genetics

    Benzinga
  2. Target And Others Insiders Have Been Buying

    Benzinga
  3. UPDATE: Bank Of America Upgrades Seattle Genetics

    Benzinga
  4. UPDATE: Bank of America Upgrades Seattle Genetics On Trial Risks

    Benzinga
  5. Benzinga's Top Upgrades

    Benzinga
  6. US Stock Futures Flat Ahead Of International Trade Data

    Benzinga
  7. Seattle Genetics Achieves Milestones Under Collaboration with Takeda for ...

    Benzinga
  8. UPDATE: H.C. Wainwright & Co. Initiates Coverage on Seattle Genetics on ...

    Benzinga
  9. UPDATE: Bank of America Reinstates Coverage on Seattle Genetics as High ...

    Benzinga
  10. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  11. Office Depot, Seattle Genetics And Others Insiders Have Been Buying

    Benzinga
  12. Seattle, Genetics Takeda Highlight Long-term Follow-up Data from ADCETRIS ...

    Benzinga
  13. Seattle Genetics Presents Interim Phase 1 from Novel Antibody-Drug Conjugate ...

    Benzinga
  14. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  15. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  16. Seattle Genetics Initiates Phase 1 LIV-1-Positive Metastatic Breast Cancer ...

    Benzinga
  17. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  18. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  19. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  20. Seattle Genetics Commences Two Phase I Trials of SGN-CD19A

    Benzinga
  21. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 2, ...

    GuruFocus
  22. Seattle Genetics and Millennium Initiate Global Phase III Clinical Trial ...

    Benzinga
  23. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,249 ...

    GuruFocus
  24. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 50,983 Shares

    GuruFocus
  25. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus
  26. Seattle Genetics Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus
  27. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 50,000 Shares

    GuruFocus
  28. Seattle Genetics Offers Data on Next-Gen Antibody-Drug Conjugate SGN-CD33A ...

    Benzinga
  29. Seattle Genetics Presents Encouraging ADCETRIS Data in CD30-Positive Non-Hodgkin ...

    Benzinga
  30. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  31. Seattle Genetics, Inc. (SGEN) COO Eric Dobmeier sells 27,327 Shares

    GuruFocus
  32. Seattle Genetics Falls After Q3 Results and Analyst Downgrade

    Benzinga
  33. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  34. Millennium, Seattle Genetics Announce Phase 3 Clinical Trial of ADCETRIS

    Benzinga
  35. Seattle Genetics Announces EC Conditional Marketing Authorization ADCETRIS

    Benzinga
  36. Seattle Genetics Will Get Undisclosed Milestone Payments

    Benzinga
  37. Schaeffer's Quantitative Analyst eyes three stocks with contrarian potential

    SchaeffersResearch
  38. Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN

    GuruFocus
  39. Seattle Genetics, Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  40. WEEKLY CFO SELLS HIGHLIGHT: SBAC, XOXO, MTH, FICO, SGEN, OAS

    GuruFocus
  41. Seattle Genetics Inc. (SGEN) CFO Todd E Simpson sells 40,000 Shares

    GuruFocus
  42. Health Care Sector Wrap

    FoxBusiness
  43. Exelixis, Universal Display Corporation Among Stocks Up on High Volume ...

    FoxBusiness
  44. Seattle Genetics Inc. Reports Operating Results (10-Q)

    GuruFocus
  45. Seattle Genetics

    IBD
  46. Seattle Genetics Inc. (SGEN) President and CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  47. Seattle Genetics Announces ADCETRIS Receives Positive CHMP Opinion for ...

    Benzinga
  48. Health Care Sector Wrap

    FoxBusiness
  49. Seattle Genetics Inc. (SGEN) President & CEO Clay B Siegall sells 8,25 ...

    GuruFocus
  50. Benzinga's Top Initiations

    Benzinga
Trading Center